Who owns Relmada Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Relmada Therapeutics stock

Who bought or sold Relmada Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 1.3M $5.8M -4% Mar 2024
 View chart
Acadian Asset Management 1.2M $5.5M 1% Mar 2024
 View chart
Parsons Capital Management 974k $4.5M 2% Mar 2024
 View chart
Opaleye Management 759k $3.5M -13% Mar 2024
 View chart
Palo Alto Investors 732k $3.4M 0% Mar 2024
 View chart
Franklin Resources 630k $2.9M 100% Mar 2024
 View chart
BlackRock 578k $2.7M 1% Mar 2024
 View chart
Millennium Management 342k $1.6M 72% Mar 2024
 View chart
Two Sigma Advisers 326k $1.5M -1% Mar 2024
 View chart
Geode Capital Management 256k $1.2M 7% Mar 2024
 View chart
Two Sigma Investments 227k $1.1M -25% Mar 2024
 View chart
Deutsche Bank Aktiengesellschaft 225k $1.0M 0% Mar 2024
 View chart
Bank of America Corporation 211k $979k 0% Mar 2024
 View chart
Marshall Wace 208k $967k 35% Mar 2024
 View chart
Bridgeway Capital Management 196k $910k 92% Mar 2024
 View chart
Guild Investment Management 191k $888k -10% Mar 2024
 View chart
Group One Trading 184k $857k 15% Mar 2024
 View chart
Jpmorgan Chase & Co 176k $818k 836% Mar 2024
 View chart
Jane Street 175k $815k 1344% Mar 2024
 View chart
Citadel Advisors 170k $788k -65% Mar 2024
 View chart
Rbf Capital 166k $770k -15% Mar 2024
 View chart
Barclays 146k $679k 0% Mar 2024
 View chart
UBS Group 129k $601k 3% Mar 2024
 View chart
Jacobs Levy Equity Management 126k $586k -41% Mar 2024
 View chart
Citigroup 124k $576k 69% Mar 2024
 View chart
Morgan Stanley 121k $560k -2% Mar 2024
 View chart
Goldman Sachs Group 118k $550k 100% Mar 2024
 View chart
GSA Capital Partners 103k $480k -44% Mar 2024
 View chart
We Are One Seven 100k $414k 0% Dec 2023
 View chart
Federated Investors 100k $413k -13% Dec 2023
 View chart
FMR 84k $390k -1% Mar 2024
 View chart
Northern Trust 81k $377k 72% Mar 2024
 View chart
Squarepoint Ops 79k $367k 8% Mar 2024
 View chart
apricus wealth 79k $367k 0% Mar 2024
 View chart
Dimensional Fund Advisors 74k $343k 0% Mar 2024
 View chart
Cantor Fitzgerald, L. P. 74k $357k 100% Mar 2024
 View chart
Qube Research & Technologies 73k $339k 1801% Mar 2024
 View chart
Man Group 72k $336k 100% Mar 2024
 View chart
AdvisorShares Investments 70k $326k -38% Mar 2024
 View chart
Cubist Systematic Strategies 51k $238k 100% Mar 2024
 View chart
Susquehanna International 50k $233k -6% Mar 2024
 View chart
Point72 Asia 50k $232k 100% Mar 2024
 View chart
Simplex Trading 47k $217k -17% Mar 2024
 View chart
Ikarian Capital 40k $188k 0% Mar 2024
 View chart
Sei Investments 36k $170k 0% Mar 2024
 View chart
Meyer Handelman 33k $151k 0% Mar 2024
 View chart
AlTi Global 32k $149k 1% Mar 2024
 View chart
Belvedere Trading 32k $147k 100% Mar 2024
 View chart
Pensionmark Financial Group 31k $143k 100% Mar 2024
 View chart
Wolverine Trading 30k $140k 7% Mar 2024
 View chart
Horizon Kinetics Asset Management 30k $124k 100% Dec 2023
 View chart
American Century Companies 28k $128k 100% Mar 2024
 View chart
Pegasus Asset Management 27k $125k 0% Mar 2024
 View chart
Connor, Clark & Lunn Investment Management 26k $123k -57% Mar 2024
 View chart
Y-Intercept 24k $112k 100% Mar 2024
 View chart
Mariner Wealth Advisors 24k $112k 15% Mar 2024
 View chart
Sargent Investment Group 22k $102k 100% Mar 2024
 View chart
Tortoise Investment Management 22k $101k 0% Mar 2024
 View chart
Spotlight Asset Group 20k $93k 0% Mar 2024
 View chart
PDT Partners 16k $76k 9% Mar 2024
 View chart
Florida State Board of Administration 15k $34k 100% Mar 2024
 View chart
Brevan Howard Capital Management 15k $69k 100% Mar 2024
 View chart
Stratos Wealth Partners 14k $66k -15% Mar 2024
 View chart
Engineers Gate Manager 14k $64k 100% Mar 2024
 View chart
Charles Schwab Investment Management 13k $58k 0% Mar 2024
 View chart
LPL Financial 13k $58k -4% Mar 2024
 View chart
Balyasny Asset Management 12k $57k 100% Mar 2024
 View chart
SG Americas Securities 11k $53k 100% Mar 2024
 View chart
Bedel Financial Consulting 10k $47k 0% Mar 2024
 View chart
Tower Research Capital 9.8k $45k 471% Mar 2024
 View chart
Cutler 9.0k $41k -3% Mar 2024
 View chart
Hexagon Capital Partners 4.0k $19k 0% Mar 2024
 View chart
Brown Brothers Harriman & Co. 3.0k $14k 0% Mar 2024
 View chart
Lindbrook Capital 2.5k $12k 0% Mar 2024
 View chart
Acima Private Wealth 1.8k $7.6k 0% Dec 2023
 View chart
American Capital Advisory 1.2k $2.7k 0% Mar 2024
 View chart
Rhumbline Advisers 1.2k $5.5k 0% Mar 2024
 View chart
ADAR1 Capital Management 601.00 $2.8k -99% Mar 2024
 View chart
GAMMA Investing 569.00 $2.6k 0% Mar 2024
 View chart
Wells Fargo & Company 543.00 $2.5k 1% Mar 2024
 View chart
Tang Capital Management 382.00 $1.8k 100% Mar 2024
 View chart
Fortitude Family Office 340.00 $1.6k 0% Mar 2024
 View chart
Massmutual Trust 113.00 $524.998000 0% Mar 2024
 View chart
Advisor Group Holdings 27.00 $126.000900 0% Mar 2024
 View chart
Front Row Advisors 6.00 $28.000200 0% Mar 2024
 View chart
Blackston Financial Advisory Group 2.00 $9.000000 100% Mar 2024
 View chart

Who sold out of Relmada Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Mirae Asset Global Investments Dec 2023 270k $1.1M
Point72 Asset Management Dec 2023 250k $1.0M
Verition Fund Management Sep 2023 34k $103k
Springbok Capital Management Sep 2023 16k $47k
Bank of New York Mellon Dec 2023 11k $46k
D. E. Shaw & Co Dec 2023 11k $44k
Royal Bank of Canada Dec 2023 4.2k $17k
Savior Sep 2023 3.5k $11k
Quantbot Technologies Sep 2023 1.5k $4.5k
Russell Investments Dec 2023 53.00 $219.001300